FDA press announcement alerts by email

Why this feed exists

An FDA decision is often the single most binary event on a biotech or pharma company's calendar. Approvals, complete response letters, and major recalls have historically moved individual stocks 5 to 15 percent in a single session. The announcement is public the moment the FDA posts it, and for a name with a decision date circled on the calendar, minutes matter.

What each alert includes

An AI headline stating the actual decision, the release excerpt with a link to the full announcement, and a Market read focused on single-stock impact: whether the outcome reads as favorable or adverse against expectations, which company and ticker it touches, and how comparable approvals, rejections, or recalls have moved shares historically.

What we filter, honestly

The FDA publishes a wide range of routine notices alongside decisions that move markets. This feed prioritizes drug and device approvals, complete response letters, black-box warnings, and significant recalls. These are the categories with a documented record of moving pharma and biotech share prices.

What it costs

Your first feed is free. One subscription covers every feed we run. See pricing.